These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 13088238)
1. The use of polyvinylpyrrolidone in the management of shock-like states; report of a case. O'CONNEL CL; GREENLEE DP; HERRON FT Pa Med J; 1953 Sep; 56(9):813-4. PubMed ID: 13088238 [No Abstract] [Full Text] [Related]
3. The use of polyvinylpyrrolidone as a plasma volume expander in preventing or combating shock. SINGLETON AO Tex Rep Biol Med; 1953; 11(1):138-43. PubMed ID: 13038721 [No Abstract] [Full Text] [Related]
7. [Subtosan therapy of shock]. DE MARCHI A; BRONNIMANN R Ther Umsch; 1952 Jun; 9(3):34-8. PubMed ID: 12995333 [No Abstract] [Full Text] [Related]
8. Plasma expanders in surgical shock. WEIL PG; BALDRY RE Can Serv Med J; 1954 Dec; 10(5):293-8. PubMed ID: 13209506 [No Abstract] [Full Text] [Related]
9. Plasma expanders in surgical shock. WEIL PG; BALDRY RE Can Hosp; 1955 May; 32(5):47; passim. PubMed ID: 14379067 [No Abstract] [Full Text] [Related]
10. [Polyvinylpyrrolidone (subtosan) as a substitute for blood plasma in the preventive and curative therapy of shock and cerebral edema]. BATTEZZATI M Boll Mem Soc Piemont Chir; 1948; 18(2-5):99-109. PubMed ID: 18878377 [No Abstract] [Full Text] [Related]
11. Polyvinylpyrrolidone in the treatment of traumatic and hemorrhagic shock and severe burns. CORDICE JW; SCUDDER J N Y State J Med; 1954 Mar; 54(5):652-8. PubMed ID: 13133124 [No Abstract] [Full Text] [Related]
12. Treatment of circulatory failure in cholera with plasma and plasmosan. BANERJI R Burma Med J; 1955 Oct; 3(4):18-21. PubMed ID: 13270090 [No Abstract] [Full Text] [Related]
13. [Polyvinylpyrrolidone preparations and the prospects of their use in medicine]. Vasil'ev PS; From AA; Suzdaleva VV Probl Gematol Pereliv Krovi; 1966 Jul; 11(7):17-9. PubMed ID: 6002174 [No Abstract] [Full Text] [Related]
14. The use of polyvinylpyrrolidone iodine in eczematoid ringworm. CORNBLEET T; BARSKY S; FIRESTEIN B AMA Arch Derm; 1958 Mar; 77(3):335-6. PubMed ID: 13507717 [No Abstract] [Full Text] [Related]
15. [Management of shock in the field of otorhinolaryngology]. HAMAGUCHI K Chiryo; 1962 Jan; 44():137-40. PubMed ID: 13904040 [No Abstract] [Full Text] [Related]
16. Current concepts on the management of shock. WEIL MH Circulation; 1957 Dec; 16(6):1097-105. PubMed ID: 13489861 [No Abstract] [Full Text] [Related]
17. Medical observations on the management of shock. STEPHENS CA Ariz Med; 1948 Jan; 5(1):50-4. PubMed ID: 18897468 [No Abstract] [Full Text] [Related]
18. The clinical value of polyvinylpyrrolidone (P.V.P.). PAMUK O; TOVELL RM Conn State Med J; 1953 Sep; 17(9):773-4. PubMed ID: 13083008 [No Abstract] [Full Text] [Related]
19. [Hepato-portal hemodynamics in experimental hemorrhagic shock. 1. Variations induced by integrating the blood volume with blood, blood and Rinter-lactate, polyvinylpyrrolidone (PVP) and low molecular weight dextran (LMWD)]. Foti F; Di Benedetto A; Russo S; Banna P; Bonfiglio S; Cirino E; Russo A G Ital Chir; 1968 Sep; 24(5):753-69. PubMed ID: 5754804 [No Abstract] [Full Text] [Related]
20. A comparison of dextran, polyvinylpyrrolidone, and isotonic saline infusion in the human. ARMSTRONG JB; DOWNEY JA; FERGUSON MH; WILLIAMS HR Can J Biochem Physiol; 1954 Nov; 32(6):636-43. PubMed ID: 13209402 [No Abstract] [Full Text] [Related] [Next] [New Search]